. . january 2014 (16) . staff blog: medicine matters . . . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . http://lm360.us/Sourwine-son-of-Kalfus-from-Santa-Fe?Roserosis=130